top of page
The purpose of this webpage and subsequent document is to provide information to existing and prospective investors, and potential commercial partners, about the current status of BCAL’s research and development. It is not intended to promote the use or supply of any therapeutic goods.
BCAL Reports
This page is intended to provide details about research and development for potential investors, commercial and distribution partners.
Annual Reports
MST Access Report 11 October. Download here
BCAL Annual Report Year Ended 30 June 2023 Download here
BCAL Half Yearly Report 23 Feb 2023 Download here
BCAL AGM Presentation November 2022. Download here
BCAL Annual Report Year Ended 30 June 2022. Download here
BCAL Preliminary Final 2021 Appendix 4E Download here
BCAL Interim Report 31 Dec 2020 Download here
BCAL Annual Report Year Ended 30 June 2020 Download here
BCAL Annual Report Year Ended 30 June 2019 Download here
MST Access Reports
-
bottom of page